Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
7.68
-0.86 (-10.13%)
At close: Dec 5, 2025, 4:00 PM EST
7.70
+0.02 (0.32%)
After-hours: Dec 5, 2025, 7:04 PM EST
Biodesix Market Cap
Biodesix has a market cap or net worth of $61.06 million as of December 5, 2025. Its market cap has decreased by -66.15% in one year.
Market Cap
61.06M
Enterprise Value
118.84M
1-Year Change
-66.15%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $61.06M, a decrease of -81.84%. That is a compound annual growth rate of -28.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 61.06M | -72.57% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |